The Valley Desk

ArticleSkinmedPublished

Retreatment with Brentuximab Vedotin for CD30+ Cutaneous T-cell Lymphoma and Lymphomatoid Papulosis

Read the publication ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Hospital of the University of Pennsylvania, Perelman School of Medicine, University of Pennsylvania, with Penn Medicine linked by the institution reference. Affiliation source

Publication record

Type
Article
Venue
Skinmed
Published
PubMed ID
39748590
Added to directory
Source checked

Report a correction or request removal